Neuroprotection 2014 - 9th Brain Research Conference Neuroprotection: Basic mechanisms and translational potential

9th Brain Research Conference
Neuroprotection: Basic mechanisms and translational potential
13-14 November 2014
Sheraton Pentagon City, Washington DC, USA
Speakers
Roberta Diaz Brinton, University of Southern California, USA
Guy Brown, University of Newcastle, Australia
Michael Chopp, Henry Ford Hospital, USA
J Timothy Greenamyre, University of Pittsburgh, USA
Etienne Hirsch, Salpêtrière Hospital, France
Lorraine Iacovitti, Thomas Jefferson University, USA
Jae-Young Koh, University of Ulsan College of Medicine, South Korea
Nick Maragakis, Johns Hopkins University, USA
Mark F. Mehler, Albert Einstein College of Medicine, USA
Diane Merry, Thomas Jefferson University, USA
Alexandre Prat, Université de Montréal, Québec, Canada
Richard M Ransohoff, Cleveland Clinic, USA
Raj Ratan, Burke Medical Research Institute/Weill Medical College of Cornell University, USA
Jeff Rothstein, Johns Hopkins University, School of Medicine, USA
David Rubinsztein, Cambridge Institute for Medical Research, UK
Michael Sofroniew, University of California Los Angeles, USA
Davide Trotti, Thomas Jefferson University, USA
Li-Huei Tsai, Massachusetts Institute of Technology, USA
The protection of neurons that are intrinsically vulnerable to diseases such as Parkinson’s, Alzheimer’s, ALS or are at risk of death due to stroke or traumatic injury is an area of immense importance. In recent years, inflammation, the blood brain barrier, stem cells, hormones and epigenetic factors have all been implicated in the rescue of neurons. Understanding these varied and complex mechanisms and the pathways they use is critical to developing interventions to preserve brain function in the diseased or injured brain.
Topics covered include:
BBB, transporters and the neurovascular unit
Cell therapy as a neuroprotective strategy
Epigenetics and therapeutic targets for neuroprotection
Hormones in neuroprotection
Pathways of protection in neurodegeneration and neuroprotection
Targeting Inflammation in neuroprotection
Translating neuroprotection to the clinic